C. Boz Et Al. , "Reduced effectiveness of long-term interferon-beta treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study," MULTIPLE SCLEROSIS , vol.13, no.9, pp.1127-1137, 2007
Boz, C. Et Al. 2007. Reduced effectiveness of long-term interferon-beta treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study. MULTIPLE SCLEROSIS , vol.13, no.9 , 1127-1137.
Boz, C., OGER, J., GIBBS, E., & GROSSBERG, S. E., (2007). Reduced effectiveness of long-term interferon-beta treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study. MULTIPLE SCLEROSIS , vol.13, no.9, 1127-1137.
Boz, CAVİT Et Al. "Reduced effectiveness of long-term interferon-beta treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study," MULTIPLE SCLEROSIS , vol.13, no.9, 1127-1137, 2007
Boz, CAVİT Et Al. "Reduced effectiveness of long-term interferon-beta treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study." MULTIPLE SCLEROSIS , vol.13, no.9, pp.1127-1137, 2007
Boz, C. Et Al. (2007) . "Reduced effectiveness of long-term interferon-beta treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study." MULTIPLE SCLEROSIS , vol.13, no.9, pp.1127-1137.
@article{article, author={CAVİT BOZ Et Al. }, title={Reduced effectiveness of long-term interferon-beta treatment on relapses in neutralizing antibody-positive multiple sclerosis patients: a Canadian multiple sclerosis clinic-based study}, journal={MULTIPLE SCLEROSIS}, year=2007, pages={1127-1137} }